<DOC>
	<DOCNO>NCT01400685</DOCNO>
	<brief_summary>Lenalidomide belongs group drug call immunomodulatory drug ( IMiD ) modify regulate functioning immune system . It FDA approve drug people multiple myeloma . It currently approve use Chronic Lymphocytic Leukemia ( CLL ) , appear effective CLL use alone , study use combination chemotherapy lymphoma leukemia . In research study hop learn effect lenalidomide CLL give combination bendamustine rituximab , highly effective regimen initial therapy CLL/SLL . The investigator look high dose lenalidomide give safely , without cause serious unmanageable side effect .</brief_summary>
	<brief_title>Lenalidomide Plus Bendamustine Rituximab Untreated CLL/SLL</brief_title>
	<detailed_description>Subjects receive lenalidomide , bendamustine rituximab cycle 28 day ( 4 week ) . Lenalidomide administer orally daily day 8-21 cycle 1 day 1-21 subsequent cycle . Bendamustine administer vein ( IV infusion ) day 1 2 cycle . Rituximab administer IV infusion day 1 cycle . Subjects receive routine blood test physical exam cycle . Tumor assessment CT scan perform cycle 2 , 4 , 6 .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<mesh_term>Bendamustine Hydrochloride</mesh_term>
	<criteria>Diagnosed Bcell CLL SLL ( chronic lymphocytic leukemia small lymphocytic leukemia ) Life expectancy &gt; 3 month Organ marrow function protocol parameter Able take aspirin daily Age &gt; 80 year Prior systemic therapy CLL/SLL include chemotherapy antibody therapy Pregnant breastfeed Serious medical condition , laboratory abnormality , psychiatric illness would prevent subject signing informed consent Known hypersensitivity thalidomide lenalidomide Prior use lenalidomide Concurrent use anticancer agent treatment HIV positive Prior history another malignancy unless disease free least 2 year Uncontrolled intercurrent illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>CLL</keyword>
	<keyword>Leukemia</keyword>
	<keyword>Untreated</keyword>
	<keyword>B-CLL</keyword>
	<keyword>SLL</keyword>
</DOC>